PRDM16 and obesity disorder: This study not only support the roles of co-stimulation of β3-adrenergic and PPARα receptors on the induction of white-to-brown adipocyte phenotypes, but also set the place for the utility of new regulators such as PRDM16 for the development of new therapeutics of complicated obesity.